A clinical study of vardhamana pippali kalpa in the management of amavata vis-a-vis rheumatoid arthritis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- effect of the vardhamana pippali kalpa in the patients of amavata
研究概览
简要总结
Clinical evaluation of the effectiveness of vardhaman pippali kalpa in the management of amavata is the main object of the study. Patients will be selected from the P D Patel ayurveda hospital, Nadiad, after the confirmation of the diagnosis of amavata with the help of classical signs and symptoms. they will be treated with Powder of pippali (Piper longum Linn.) in vardhmana krama,i.e. starting the dose from 1 gm on the first day, twice a day with hot water will given. It will be increased by 1 gm daily up to a maximum dose of 5 gm twice a day. The maximum dose, i.e.5 gm will be given for 5 days and then it will be tapered by 1 gm daily to a dose of 1 gm twice a day. Patients will be kept on mudgayuá¹£a. Total duration of the treatment will be of 13 days. Assessment will be done with the help of changes in gradation of the signs and symptoms of amavata, ESR, DAS-28 scale, disability index (the indian health assessment questionnaire). Result will be analysed with student t test.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Presence of sandhiÅ›ula (pain in joints), sandhijÄdyatÄ (stiffness in joints), sandhisotha (swelling in joints), restriction of movement.
- •2.Presence of any six out of the following ten classification criteria and European league against rheumatism (EULAR).
排除标准
- •1.Patients who have developed complications of rheumatoid arthritis e.g. Severe deformity of jointsones, pleura-pericardial disease, or else.
- •2.Association of a joint disease of other origin.
- •3.Patients having HbA1c above 7.5 of diabetes mellitus.
- •4.Patients on prolonged medication with immunosuppressive e.g. corticosteroids any other drugs within last 6 months that may have an influence on the outcome of the study.
- •5.Pregnant/lactating women.
结局指标
主要结局
effect of the vardhamana pippali kalpa in the patients of amavata
时间窗: Grade score of signs and symptoms
次要结局
未报告次要终点
